Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Stomach Neoplasms 4Neuroblastoma 4Fallopian Tube Neoplasms 4Urinary Bladder Neoplasms 3Ovarian Neoplasms 3Medulloblastoma 3Ganglioneuroblastoma 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Brain Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Brenner Tumor 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solid Neoplasms 1Sarcoma 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1

Interventions

osimertinib 2Vinorelbine 2Pemetrexed 2Liquid Biopsy 2HMPL-013 2Gefitinib 2Carboplatin 2tislelizumab 1sulindac sulfone 1rezivertinib 1pembrolizumab 1anlotinib 1Radiotherapy 1Platinum 1Paclitaxel 1Gemcitabine 1Cisplatin 1Cetuximab 1CP protocol 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × NSCLC × Platinum × Clear all
NCT01769066 2016-02-23

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Fudan University

Phase 2/3 Completed
117 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡